Browsing Tag
LSE
3 posts
GSK to sell linerixibat rights to Alfasigma for up to $690m as rare liver disease drug nears FDA approval
GSK and Alfasigma agree worldwide licence for linerixibat, a rare liver disease itch drug nearing FDA approval. Deal worth up to $690 million. Read more.
Pan African Resources (LSE: PAF) to acquire Emmerson Resources (ASX: ERM) in £163m deal to consolidate Tennant Creek
Pan African Resources agrees to acquire Emmerson Resources in a A$311m all-share deal, consolidating the Tennant Creek gold district. Read full analysis.
New World Resources to be acquired by Central Asia Metals in A$185m all-cash deal
Central Asia Metals to acquire New World Resources for A$185M in cash. See why Antler Copper Project was key to the 150% premium deal.